The following funding opportunities are specific to COVID-19. The list will be updated as new opportunities arise.

Sponsor Program Amount (max, if range) Deadline 
National Institutes of Health (NIH) NCI, NCCIH, NHGRI, NIAID, NICHD, NIDDK, NIEHS, NIGMS, NIMHD, NIBIB,NCATS Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional) Not limited See Emergency Notice of Special Interest by IC
COVID-19 Early Treatment Fund (CETF) Funding for Outpatient Trials Up to $1M Currently accepting applications
Cisco Pandemic/COVID-19 Science, Technology and Social Impact Unspecified  Unspecified 
Autism Speaks COVID-19 Call for Resources N/A Unspecified 
Biogen Foundation (typically funds Boston, MA & Research Triangle,NC) COVID-19 Response Unspecified (up to $10M in total funding) Unspecified (accepting applications)
Draper Richards Kaplan Foundation EWDRK Covid-19 Urgent Response Initiative (CURI) $50,000-$100,000 (CURI invests 25% maximum of total) Unspecified 
Merck KGaA (Germany) Research Grant for Pandemic Preparedness 1,500,000 Euros Applications accepted on a rolling basis
Mozilla COVID-19 Solutions Fund $50,000 Applications accepted on a rolling basis
Patient-Centered Outcomes Research Institute (PCORI) PCORI Funding Opportunity for COVID-19-Related Enhancements to Existing PCORI-Funded Engagement Awards $150,000 Applications accepted on a rolling basis
Patient-Centered Outcomes Research Institute (PCORI) PCORI Funding Opportunity for COVID-19-Related Enhancements to Existing PCORI-Funded Research Projects $500,000 Applications accepted on a rolling basis
National Institutes of Health (NIH) NINDS Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System $200,000 (direct costs) Applications accepted until 4/14/2021
National Institutes of Health (NIH) NIAID Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Budgets should reflect the actual needs Applications accepted until 7/2/2021
National Institutes of Health (NIH)

NIAID

Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) Budgets should reflect actual needs (direct costs only) Applications accepted until 7/8/2021
National Institutes of Health (NIH) NIA, NIAID, NIDDK, NIDA, NIMH, NIEHS, NICHD, NIAAA, NIBIB, NHGRI, NIMHD, NCATS, NIDCH, NCI Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement – Clinical Trial Optional) Must reflect your needs Varies by awarding IC
National Institutes of Health (NIH) NIAID Administrative Supplement Not limited 2/6/2020 (applications accepted through 2/6/2021)
National Institutes of Health (NIH) NIGMS Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 Must reflect your needs 3/5/2020 (applications accepted through 2/5/2021)
Department of Energy (DOE) Invitation for COVID-19 Scientific questions DOE Resources 3/18/2020 (reviews start 3/18 but accepted on a rolling basis)
National Institutes of Health (NIH) NIDA Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus $100K direct costs/yr 3/19/2020 (applications accepted through 3/31/2021)
National Institutes of Health (NIH) NIDA  Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Must reflect your needs 3/25/2020 (applications accepted through 3/25/2021)
National Institutes of Health (NIH) NIMH, NIA, NIAAA, NIMHD Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus Contact program officer 3/27/2020 (applications accepted through 4/15/2021)
National Institutes of Health (NIH) NCATS Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Check RFA(s) within 4/5/2020 (application deadlines through 4/5/2021)
National Institutes of Health (NIH) NIA, NIMH Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) Must reflect your needs 4/6/2020 (applications accepted through 5/1/2021)
National Institutes of Health (NIH) OBSSR, NHLBI, NIA, NIAAA, NIDDK, NIEHS, NCCIH, NCI Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences $200,000 (direct costs) 4/13/2020 (applications accepted until 3/31/2021)
Ferring Pharmaceuticals Ferring COVID-19 Investigational Grants  25,000 Euros 4/15/2020 (applications accepted through 10/31/2020)
National Institutes of Health (NIH) NIBIB Point-of-Care Technology Research Network (POCTRN) Fast-Track Program for COVID-19 Test Development and Distribution) Phase 0: $25,000 Rolling (selection process began 4/29/2020)
National Institutes of Health (NIH) NIAID Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed) $275,000 (direct costs) 4/30/2020 (Applications accepted until 4/30/2021)
National Institutes of Health (NIH) NIAID NEWEmergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed) Budgets must reflect the actual needs 4/30/2020 (Applications accepted until 4/30/2021)
National Institutes of Health (NIH) NIMHD, NIA, NIMH Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities $125,000 (direct costs) 5/1/2020 (applications accepted through 5/1/2021)
National Institutes of Health (NIH) NIEHS Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) Must reflect your needs 5/1/2020, 6/1/2020 (other deadlines within)
National Institutes of Health (NIH) NCATS Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs Budgets must reflect the actual needs 5/4/2020 (applications accepted until 11/10/2020)
National Institutes of Health (NIH) NIAID, NIA Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) Not limited 5/13/2020; 9/13/2020; and others
National Institutes of Health (NIH) NIAAA Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA $200,000 (direct costs) 5/15/2020 (applications accepted until 4/15/2021)
National Institutes of Health (NIH) NCATS Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus Limited to amount of current parent 5/15/2020 (applications accepted until 1/25/2022)
National Institutes of Health (NIH) NCATS Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus Limited to no more than 25% total costs of the amount of the current parent award 5/15/2020 (applications accepted until 1/25/2022)
National Institutes of Health (NIH) NCATS Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) Check RFA(s) within 6/5/2020 (other later deadlines within)
National Institutes of Health (NIH) NIMHD, NEI, NHLBI, NIA, NIAAA, NICHD, NIDCR, NIDDK, NIDA, NIEHS,NIMH, NCCIH, NCATS Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations $250,000 (direct costs) 6/10/2020 (applications accepted until 12/15/2020)
National Institutes of Health (NIH) NIMHH, NEI,NHLBI, NIA, NIAAA, NICHD,NIDCD, NIDCR, NIDDK, NIDA, NINR, NIMHD, NCCIH, NCATS Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 $200,000 (direct costs) 6/10/2020 (applications accepted until 12/15/2020)
National Institutes of Health (NIH) NIA NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required) Must reflect your needs 7/1/2020; 8/3/2020; and others
National Institutes of Health (NIH) OD, NHLBI, NHGRI, NIA, NIAID, NIAMS, NICHD, NIDCD, NIDCR, NIDDK, NIEHS, NINDS, NIMHD, NCCIH, NCATS, ORIP, NCI Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project $1,000,000 (direct costs) 7/13/2020; 11/12/2020; other deadlines within
National Institutes of Health (NIH) NCATS Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required)  $9M (direct costs) 8/6/2020 (applications accepted until 1/24/2021)
National Institutes of Health (NIH) OD, NIMHD, NIA, NEI, NHLBI, NHGRI, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIGMS, NINDS, NIMH, NINR, NLM, FIC, NCCIH, NCATS, NCI Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) $2.5M (direct costs) 8/28/2020; 12/1/2020
National Institutes of Health (NIH) NIAID Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2   9/14/2020; 10/14/2020; 11/14/2020 (other deadlines within)
Found for Women's Cancer Diversity and Inclusion Health Equity Research Grant $75,000 Abstract: 9/21/2020
Full proposal: 11/25/2020
Patient-Centered Outcomes Research Institute PCORI) Phased Large Awards in Comparative Effectiveness Research (PLACER) $22M 9/29/2020 (LOI) ;
Full app: 1/12/2021
National Institutes of Health (NIH) NICHD Notice of Special Interest: Emerging Viral Infections and their Impact on the Male and Female Reproductive Tract Must reflect your needs 10/5/2020 (subsequent receipt dates through 7/16/2023)
National Institutes of Health (NIH) NIDCD Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders Varies (see RFAs within) 10/5/2020 (subsequent receipt dates through 9/8/2022)
National Institutes of Health (NIH) NIMHD, NIA, NIDA, NCI Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) Not limited 10/5/2020 (and standard R01 deadlines)
National Institutes of Health (NIH) NIMHD, NIAMS, NIDA, NIMH, NLM, NCI Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities Must reflect your needs 10/5/2020 (subsequent receipt dates through 5/8/2023)
National Institutes of Health (NIH) NHLBI Notice of Special Interest (NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI) Must reflect your needs 10/5/2020 (subsequent receipt dates through 7/5/2024)
Biomedical Advanced Research and Development Authority (BARDA) Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) Negotiated after white paper stage 10/31/2020 (white paper & full application)
National Institutes of Health (NIH) NIMHD, NIAAA, NIDA Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional) Must reflect your needs 11/27/2020 (subsequent receipt dates within RFA)
National Institutes of Health (NIH) NIDDK Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional) $750,000 (direct costs) 12/16/2020
IBSA for Scientific Research The IBSA Foundation Fellowships € 30,000 12/31/2020
National Institutes of Health (NIH) NIDA Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection Varies (see RFAs within) 1/4/2021 (applications accepted through 9/8/2024)
National Institutes of Health (NIH) NIDA Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection Varies (see RFAs within) 1/7/2021 (subsequent receipt dates through 9/8/2024)
Centers for Disease Control (CDC) Annual Estimates of Influenza Vaccine Effectiveness for Preventing Medically Attended Laboratory-Confirmed Influenza in the United States $2,150,000 1/8/2021
National Institutes of Health (NIH) NIAID Emergency Awards: Notice of Special Interest (NOSI) on Pan-Coronavirus Vaccine Development Program Projects $500,000 (max annual direct costs without prior approval) 1/11/2021 and 6/11/2021
Johnson & Johnson Innovation (JLABS) Nurses Innovate QuickFire Challenge on Mental Health $100,000 1/15/2021
National Institutes of Health (NIH) NICHD Notice of Special Interest (NOSI) – Research on Rehabilitation Needs Associated with the COVID-19 Pandemic Must reflect your needs 2/5/2021 (subsequent receipt dats through 5/8/2023)
National Institutes of Health (NIH) NCATS Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) Varies (see RFAs within) 3/16/2021
The Founding Members The Trinity Challenge Unspecified 4/1/2021
National Science Foundation (NSF) RAPID: Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) $200,000 Check with program officers